-
1
-
-
10344263126
-
-
Japanese source
-
-
-
-
2
-
-
0024759611
-
Immunotherapy of renal cell carcinoma
-
Graham, S.D. Jr.: Immunotherapy of renal cell carcinoma Semin. Urol., 4, 215-227, 1989.
-
(1989)
Semin. Urol.
, vol.4
, pp. 215-227
-
-
Graham Jr., S.D.1
-
3
-
-
0019514428
-
Spontaneous regression of metastasis of renal cancer
-
Fairlamb, D.J.: Spontaneous regression of metastasis of renal cancer. Cancer, 47, 2102-2106, 1981.
-
(1981)
Cancer
, vol.47
, pp. 2102-2106
-
-
Fairlamb, D.J.1
-
4
-
-
10344220763
-
-
Japanese source
-
-
-
-
5
-
-
0024467415
-
An assessment of the current use of human interferons in therapy of urological cancers
-
Horoszewicz, J.S. and Murphy, G.P : An assessment of the current use of human interferons in therapy of urological cancers. J. Urol , 142, 1173-1180, 1989.
-
(1989)
J. Urol
, vol.142
, pp. 1173-1180
-
-
Horoszewicz, J.S.1
Murphy, G.P.2
-
6
-
-
0022455717
-
Phase II study of alpha interferon on renal cell carcinoma : Summary of three collaborative trials
-
Umeda, T. and Nijima, T.: Phase II study of alpha interferon on renal cell carcinoma : Summary of three collaborative trials. Cancer, 58, 1231-1235, 1986.
-
(1986)
Cancer
, vol.58
, pp. 1231-1235
-
-
Umeda, T.1
Nijima, T.2
-
7
-
-
0021263729
-
Inhibition of T suppressor cell expression by histamine type 2 (H2) receptor antagonists
-
Griswold, D.E., Alessi, S , Badger, A.M., Poste, G. and Hanna, N.: Inhibition of T suppressor cell expression by histamine type 2 (H2) receptor antagonists. J Immunol., 132, 3054-3057, 1984.
-
(1984)
J Immunol.
, vol.132
, pp. 3054-3057
-
-
Griswold, D.E.1
Alessi, S.2
Badger, A.M.3
Poste, G.4
Hanna, N.5
-
8
-
-
0024470401
-
Cimetidine in malignant malanoma
-
Timm, E.G. and Rozek, S.L.: Cimetidine in malignant malanoma. Ann. Pharmacother., 23, 689-690, 1989.
-
(1989)
Ann. Pharmacother.
, vol.23
, pp. 689-690
-
-
Timm, E.G.1
Rozek, S.L.2
-
9
-
-
0023270344
-
Histamine type-2 receptor antagonist immune modulation II. Cimetidine increase interleukin-2 production
-
Grifford, R R M. and Tilberg, A.F.: Histamine type-2 receptor antagonist immune modulation II. Cimetidine increase interleukin-2 production. Surgery, 102, 242-247, 1987.
-
(1987)
Surgery
, vol.102
, pp. 242-247
-
-
Grifford, R.R.M.1
Tilberg, A.F.2
-
11
-
-
0023816023
-
Effects of cimetidine on survival after gastoric cancer
-
Tonnesen, H., Knigge, U., Buelow, S., Damm, P., Fischerman, K., Hesselfeldt, P., Hjortrup, A., Pedersen, I.K , Pedersen, V.M., Siemssen, O.J., Svendsen, L.B. and Christiansen, P.M : Effects of cimetidine on survival after gastoric cancer. Lancet, 332, 990-991, 1988.
-
(1988)
Lancet
, vol.332
, pp. 990-991
-
-
Tonnesen, H.1
Knigge, U.2
Buelow, S.3
Damm, P.4
Fischerman, K.5
Hesselfeldt, P.6
Hjortrup, A.7
Pedersen, I.K.8
Pedersen, V.M.9
Siemssen, O.J.10
Svendsen, L.B.11
Christiansen, P.M.12
-
12
-
-
10344245791
-
-
Japanese source
-
-
-
-
13
-
-
10344219702
-
Phase II study of high-dose cimetidine in renal cell carcinoma: A trial of the hooser oncology group (HOG)
-
Inhorn, L., Pennington, K., Miller, M., Meyer, S., Stephens, D. and Williams, S : Phase II study of high-dose cimetidine in renal cell carcinoma: A trial of the hooser oncology group (HOG). Proc Am. Soc. Clin. Oncol., 8, 148, 1989.
-
(1989)
Proc Am. Soc. Clin. Oncol.
, vol.8
, pp. 148
-
-
Inhorn, L.1
Pennington, K.2
Miller, M.3
Meyer, S.4
Stephens, D.5
Williams, S.6
-
14
-
-
0026577981
-
High-dose cimetidine for the treatment of metastatic renal cell carcinoma
-
Inhorn, L., Williams, S., Nattam, S. and Stephens, D.: High-dose cimetidine for the treatment of metastatic renal cell carcinoma. Am. J Clin. Oncol., 15, 157-159, 1992.
-
(1992)
Am. J Clin. Oncol.
, vol.15
, pp. 157-159
-
-
Inhorn, L.1
Williams, S.2
Nattam, S.3
Stephens, D.4
|